- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03525106
Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers
Feasibility of a Positive Psychology Intervention for Hematopoietic Cell Transplant Survivors to Improve Quality of Life
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
PRIMARY OBJECTIVES:
I. Pilot a positive psychology intervention delivered to hematopoietic cell transplantation (HCT) survivors and interested caregivers over an 8 week period.
II. Determine the proportion of patients who enroll and the immediate benefit to participants, as measured by pre- and post-exercise measures of happiness and optimism.
III. Pilot outcome data collection mechanisms in preparation for a randomized clinical trial.
OUTLINE:
Participants and caregivers receive a positive psychology exercise manual, complete positive psychology exercises every week, and participate in phone sessions over 30 minutes every week for 8 weeks.
After completion of study, participants are followed up at 6 months.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Washington
-
Seattle, Washington, Förenta staterna, 98109
- Fred Hutch/University of Washington Cancer Consortium
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Written informed consent
- English as primary language
- At least 1 year after HCT
Exclusion Criteria:
- Major psychiatric diagnosis that impairs cognitive functioning or is not controlled at the time of the approach.
- Medical conditions precluding participation in the intervention or likely to lead to death within 6 months, as determined by the principal investigator (PI)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Participants: Positive Psychology Intervention
Participants receive a positive psychology exercise manual, complete positive psychology exercises every week, and participate in phone sessions over 30 minutes every week for 8 weeks.
|
Sidostudier
Andra namn:
Sidostudier
Receive positive psychology manual
Andra namn:
Complete positive psychology exercises
Participate in phone sessions
|
Experimentell: Caregivers: Positive Psychology Intervention
Caregivers receive a positive psychology exercise manual, complete positive psychology exercises every week, and participate in phone sessions over 30 minutes every week for 8 weeks.
|
Sidostudier
Andra namn:
Sidostudier
Receive positive psychology manual
Andra namn:
Complete positive psychology exercises
Participate in phone sessions
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Study enrollment rates
Tidsram: Up to 8 weeks
|
The analysis of the study will mainly be descriptive. The proportion of participants who consent to enroll in the study will be computed based on the number approached through each method. Reasons for non-participation will be summarized. A larger randomized trial will be considered feasible if the enrollment rate for patients approached in person or over the phone is > 50% (excluding the active opt-out rate) and the overall completeness of follow-up data collection is > 70%, excluding patients who have died or are hospitalized/ill at the assessment point. Since the number of caregivers who will participate is unknown, caregiver analyses will also be descriptive only. |
Up to 8 weeks
|
Positive psychology intervention completion rates
Tidsram: Up to 8 weeks
|
Up to 8 weeks
|
|
Completeness of follow-up data collection
Tidsram: Up to 8 weeks
|
Completeness is defined by the proportion of instrument scores that can be calculated per given time point.
The completeness of follow-up data collection will be calculated and reported as a proportion of successfully completed scales versus scales attempted to be collected or completed by patients.
|
Up to 8 weeks
|
Changes in happiness after each exercise
Tidsram: Baseline up to 8 weeks
|
Change in happiness for each exercise will be analyzed by change scores.
A change of 2 points on a 0-10 scale, with 10 being happiest, is considered clinically meaningful.
|
Baseline up to 8 weeks
|
Changes in optimism after each exercise
Tidsram: Baseline up to 8 weeks
|
Change in optimism for each exercise will be analyzed by change scores.
A change of 2 points on a 0-10 scale, with 10 being most optimistic, is considered clinically meaningful.
|
Baseline up to 8 weeks
|
Changes in mental health
Tidsram: Baseline up to 6 months after intervention ends
|
This will be assessed with the patient-reported outcomes measurement information system, PROMIS-10 (Global-Mental).
Higher scores are better.
T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.
|
Baseline up to 6 months after intervention ends
|
Changes in physical health
Tidsram: Baseline up to 6 months after intervention ends
|
This will be assessed with the patient-reported outcomes measurement information system, PROMIS-10 (Global-Physical).
Higher scores are better.
T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.
|
Baseline up to 6 months after intervention ends
|
Changes in fatigue
Tidsram: Baseline up to 6 months after intervention ends
|
This will be assessed with the patient-reported outcomes measurement information system, PROMIS-Fatigue.
Lower scores are better.
T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.
|
Baseline up to 6 months after intervention ends
|
Changes in pain
Tidsram: Baseline up to 6 months after intervention ends
|
This will be assessed with the patient-reported outcomes measurement information system, PROMIS-Pain interference.
Lower scores are better.
T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.
|
Baseline up to 6 months after intervention ends
|
Changes in resilience
Tidsram: Baseline up to 6 months after intervention ends
|
This will be assessed with the Connor Davidson resilience scale.
Total scores range from 0-40 with higher scores reflecting great resilience.
|
Baseline up to 6 months after intervention ends
|
Changes in anxiety and depression
Tidsram: Baseline up to 6 months after intervention ends
|
The Hospital Anxiety and Depression Scale will be used to capture depression and anxiety.
Scores on the Anxiety and Depression subscales range from 0-21 with higher scores indicating more distress.
Subscales will be reported separately.
|
Baseline up to 6 months after intervention ends
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 9969 (Annan identifierare: Fred Hutch/University of Washington Cancer Consortium)
- P30CA015704 (U.S.S. NIH-anslag/kontrakt)
- NCI-2018-00541 (Registeridentifierare: CTRP (Clinical Trial Reporting Program))
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Hematopoetisk celltransplantationsmottagare
-
Ruijin HospitalRekryteringLymfom, stor B-cell, diffus | Kemoterapi | TransplantationKina
-
Ruijin HospitalHar inte rekryterat ännuLymfom, stor B-cell, diffus | Kemoterapi | TransplantationKina
-
Cell Medica LtdAvslutadLymfom, stor B-cell, diffus | Hodgkins lymfom | Lymfoproliferativ störning efter transplantationFörenta staterna
-
Baylor College of MedicineNational Cancer Institute (NCI)AvslutadDiffust stort B-cellslymfom | Lymfoproliferativ störning efter transplantation | Primärt mediastinalt (tymiskt) stort B-cellslymfomFörenta staterna
-
University of WashingtonRekryteringÅterkommande mantelcellslymfom | Refraktärt B-cells non-Hodgkin-lymfom | Återkommande B-cells non-Hodgkin lymfom | Återkommande diffust stort B-cellslymfom | Refraktärt diffust stort B-cellslymfom | Lymfoproliferativ störning efter transplantation | Refraktärt mantelcellslymfom | Återkommande follikulärt... och andra villkorFörenta staterna
-
Pierluigi PorcuMillennium Pharmaceuticals, Inc.; Celgene CorporationAvslutadPerifert T-cellslymfom | Anaplastiskt storcelligt lymfom | Angioimmunoblastiskt T-cellslymfom | Vuxen nästyp Extranodal NK/T-cellslymfom | Hepatospleniskt T-cellslymfom | Lymfoproliferativ störning efter transplantation | Återkommande vuxen T-cell leukemi/lymfom | Återkommande kutant T-cell non-Hodgkin... och andra villkorFörenta staterna
-
Singapore General HospitalAvslutadAngioimmunoblastiskt T-cellslymfom | Hepatospleniskt T-cellslymfom | Perifert T-cellslymfom (ej specificerat på annat sätt) | Extranodal NK/T-cellslymfom nästyp | Enteropati - Typ T-cellslymfom | Anaplastiskt storcelligt lymfom (ALCL) (ALK-1 negativ) | Återfall av ALCL (ALK-1 positiv) efter autolog...Singapore, Malaysia, Korea, Republiken av
-
Novartis PharmaceuticalsAvslutadMultipelt myelom | Non-Hodgkins lymfom | Kronisk lymfatisk leukemi | Myelodysplastiskt syndrom | Akut lymfatisk leukemi | Transplantation av enkel navelsträngsblod | Icke-myeloablativ konditioneringFörenta staterna
-
Mayo ClinicNational Cancer Institute (NCI)AvslutadExtranodal marginalzon B-cellslymfom i slemhinneassocierad lymfoid vävnad | Nodal marginalzon B-cellslymfom | Återkommande vuxen Burkitt lymfom | Återkommande vuxen diffust storcelligt lymfom | Återkommande vuxen lymfatisk lymfom | Återkommande follikulärt lymfom grad 1 | Återkommande follikulärt... och andra villkorFörenta staterna
-
Mayo ClinicAvslutadExtranodal marginalzon B-cellslymfom i slemhinneassocierad lymfoid vävnad | Nodal marginalzon B-cellslymfom | Återkommande vuxen Burkitt lymfom | Återkommande vuxen diffust storcelligt lymfom | Återkommande follikulärt lymfom grad 1 | Återkommande follikulärt lymfom grad 2 | Återkommande follikulärt... och andra villkorFörenta staterna
Kliniska prövningar på Livskvalitetsbedömning
-
Memorial Sloan Kettering Cancer CenterAvslutadAscitesFörenta staterna
-
CelgeneAvslutadMyelodysplastiska syndrom | Multipelt myelom | Leukemi Myeloid Akut | Leuklemi, lymfocytisk, kroniskSpanien
-
Latin American Cooperative Oncology GroupRoche Pharma AG; EVA - Grupo Brasileiro de Tumores GinecológicosAvslutadLivmoderhalscancerBrasilien
-
Tanta UniversityRekryteringLivskvalité | Malocklusion | Korsbett | TalEgypten
-
Maastricht UniversityTNO; Netherlands Instititute for Health Services Research; University of...AvslutadHjärtsvikt | Diabetes mellitus, typ 2 | Kronisk obstruktiv lungsjukdom | AstmaNederländerna
-
World Vision CanadaRyerson University; World Health Organization; Global Affairs Canada; Ministry...AvslutadDiarre | Malaria | Akut luftvägsinfektion
-
Fatih Sultan Mehmet Training and Research HospitalAktiv, inte rekryterande
-
University Hospital, Strasbourg, FranceAvslutadKirurgiskt ingrepp | MindreFrankrike
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustAvslutad
-
Federal University of Minas GeraisConselho Nacional de Desenvolvimento Científico e TecnológicoOkändDepression | Muskelsjukdomar | Värmevallningar | Ångest | Premenstruell spänningBrasilien